These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31975402)

  • 41. Incidence of Guillain-Barré syndrome among Zika virus infected cases: a report from Thailand.
    Joob B; Wiwanitkit V
    Arq Neuropsiquiatr; 2018 Jan; 76(1):63. PubMed ID: 29364400
    [No Abstract]   [Full Text] [Related]  

  • 42. Flavivirus cross-reactivity in serological tests and Guillain-Barré syndrome in a hematopoietic stem cell transplant patient: A case report.
    Raboni SM; Bonfim C; Almeida BM; Zanluca C; Koishi AC; Rodrigues PRVP; Kay CK; Ribeiro LL; Scola RH; Duarte Dos Santos CN
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28306183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased rates of Guillain-Barré syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil.
    Styczynski AR; Malta JMAS; Krow-Lucal ER; Percio J; Nóbrega ME; Vargas A; Lanzieri TM; Leite PL; Staples JE; Fischer MX; Powers AM; Chang GJ; Burns PL; Borland EM; Ledermann JP; Mossel EC; Schonberger LB; Belay EB; Salinas JL; Badaro RD; Sejvar JJ; Coelho GE
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005869. PubMed ID: 28854206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging arboviruses in Rio Grande do Sul, Brazil: Chikungunya and Zika outbreaks, 2014-2016.
    Gregianini TS; Ranieri T; Favreto C; Nunes ZMA; Tumioto Giannini GL; Sanberg ND; da Rosa MTM; da Veiga ABG
    Rev Med Virol; 2017 Nov; 27(6):. PubMed ID: 28929534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Zika virus: Report from the task force on tropical diseases by the world Federation of Societies of intensive and critical care medicine.
    Silva GS; Richards GA; Baker T; Hidalgo J; Jiménez JIS; Amin P;
    J Crit Care; 2018 Aug; 46():106-109. PubMed ID: 29779827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guillain-Barré syndrome associated with Zika virus infection in Brazil: a cost-of-illness study.
    Peixoto HM; Romero GAS; de Araújo WN; de Oliveira MRF
    Trans R Soc Trop Med Hyg; 2019 May; 113(5):252-258. PubMed ID: 30892628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Zika Virus and Guillain-Barré Syndrome].
    Koike H
    Brain Nerve; 2018 Feb; 70(2):113-120. PubMed ID: 29433112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and nerve conduction features in Guillain-Barré syndrome associated with Zika virus infection in Cúcuta, Colombia.
    Uncini A; González-Bravo DC; Acosta-Ampudia YY; Ojeda EC; Rodríguez Y; Monsalve DM; Ramírez-Santana C; Vega DA; Paipilla D; Torres L; Molano-González N; Osorio JE; Anaya JM
    Eur J Neurol; 2018 Apr; 25(4):644-650. PubMed ID: 29266602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013.
    Oehler E; Watrin L; Larre P; Leparc-Goffart I; Lastere S; Valour F; Baudouin L; Mallet H; Musso D; Ghawche F
    Euro Surveill; 2014 Mar; 19(9):. PubMed ID: 24626205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Guillain-Barré syndrome risk among individuals infected with Zika virus: a multi-country assessment.
    Mier-Y-Teran-Romero L; Delorey MJ; Sejvar JJ; Johansson MA
    BMC Med; 2018 May; 16(1):67. PubMed ID: 29759069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of Zika Virus in April 2013 Patient Samples, Rio de Janeiro, Brazil.
    Passos SRL; Borges Dos Santos MA; Cerbino-Neto J; Buonora SN; Souza TML; de Oliveira RVC; Vizzoni A; Barbosa-Lima G; Vieira YR; Silva de Lima M; Hökerberg YHM
    Emerg Infect Dis; 2017 Dec; 23(12):2120-2121. PubMed ID: 28953451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zika virus infection: epidemiology, clinical manifestations and diagnosis.
    Calvet GA; Santos FB; Sequeira PC
    Curr Opin Infect Dis; 2016 Oct; 29(5):459-66. PubMed ID: 27496713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evidence based guidelines. Diagnosis and management of Guillain-Barré syndrome in ten steps].
    Leonhard SE; Mandarakas MR; de Assis Aquino Gondim F; Bateman K; Brito Ferreira ML; Cornblath DR; Van Doorn PA; Dourado ME; Hughes RAC; Islam B; Kusunoki S; Pardo CA; Reisin R; Sejvar JJ; Shahrizaila N; Soares C; Umapathi T; Wang Y; Yiu EM; Willison HJ; Jacobs BC
    Medicina (B Aires); 2021; 81(5):817-836. PubMed ID: 34633957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Guillain-Barre syndrome and Zika infection: identifying leading producers, countries relative specialization and collaboration.
    Perez-Cabezas V; Ruiz-Molinero C; Nuñez-Moraleda B; Jimenez-Rejano JJ; Chillón-Martinez R; Moral-Munoz JA
    FEMS Microbiol Lett; 2019 Mar; 366(5):. PubMed ID: 30759205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Zika virus infection: A review].
    Guillier A; Amazan E; Aoun A; Baubion E; Derancourt C
    Ann Dermatol Venereol; 2017; 144(8-9):518-524. PubMed ID: 28673675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-Time Assessment of Health-Care Requirements During the Zika Virus Epidemic in Martinique.
    Andronico A; Dorléans F; Fergé JL; Salje H; Ghawché F; Signate A; Daudens-Vaysse E; Baudouin L; Dub T; Aubry M; Cao-Lormeau VM; Ledrans M; Noel H; Mallet HP; Fontanet A; Cabié A; Cauchemez S
    Am J Epidemiol; 2017 Nov; 186(10):1194-1203. PubMed ID: 28200111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Zika, a neurotropic virus?].
    Del Carpio-Orantes L
    Rev Med Inst Mex Seguro Soc; 2016; 54(4):540-3. PubMed ID: 27197113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zika Virus: A Critical Analysis and Pharmaceutical Perspectives.
    Sultan N; Bukhari SA; Ali I; Asif M; Umar Z; Akash MSH
    Crit Rev Eukaryot Gene Expr; 2018; 28(4):357-371. PubMed ID: 30311585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Augmented Zika and Dengue Neutralizing Antibodies Are Associated With Guillain-Barré Syndrome.
    Lynch RM; Mantus G; Encinales L; Pacheco N; Li G; Porras A; Mendoza AR; Peng J; Rengifo-Pardo M; Cruz MM; Harris E; Bethony JM; Simon GL; Chang AY
    J Infect Dis; 2019 Jan; 219(1):26-30. PubMed ID: 30113672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.